<DOC>
	<DOCNO>NCT00650897</DOCNO>
	<brief_summary>Patients diabetes major depression treat Escitalopram might experience significant improvement depression anxiety score ; functional ability ; diabetes-related self-care ; pain symptom</brief_summary>
	<brief_title>Efficacy Study Escitalopram Depression Patients With Diabetes</brief_title>
	<detailed_description>Major depression common patient diabetes ( point prevalence 15-20 % ) . It show patient diabetic major depression experience severe diabetes symptom , great disability , frequent medical complication , great healthcare utilization cost , poor glycemic control , great difficulty diabetes self-care activity , compare patient diabetes without depression . Few specific feature Escitalopram , selective serotonin reuptake inhibitor ( SSRI ) , make promising medication use diabetes . These include benign side effect profile ; high tolerance elderly patient ; rapid action efficacy often demonstrate little 1-2 week , turn could help improve compliance ; efficacy treatment generalize anxiety disorder , may also relatively common patient diabetes , co-occurs frequently depression . This study design test efficacy Escitalopram treatment major depression patient diabetes mellitus .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Age 18 year old . Diagnosis Type1 Type2 diabetes mellitus ( exclude gestational diabetes ) specialist least 6 month prior study . Current diagnosis major depression base DSMIV criterion . Hamilton Depression Rating Scale ( HAMD ) baseline score &gt; 17 Available 14weeks treatment evaluation . Able understand study rule procedure willing sign write informed consent study participation . Competence : Not competent understand sign inform consent form and/or understand answer evaluation . Psychiatric exclusion : One following : Alcohol substance abuse dependence past 6 month ; psychotic symptom history psychosis ; bipolar disorder ; organic brain syndrome ; significant suicide risk ; homicidal thought . Medical exclusion : Known intolerance hypersensitivity escitalopram SSRI ; pregnancy ; breastfeeding ; woman childbearing potential use adequate contraception ; significant renal hepatic dysfunction ( demand medical workup and/or regular follow ) ; rest heart rate le 40/minute ( 50/minute symptomatic ) ; uncontrolled hypertension ( systolic blood pressure &gt; 180 mm Hg diastolic blood pressure &gt; 100 mm Hg ) ; acute unstable medical condition might interfere safe conduct study . Concomitant medication ( ) exclusion : Current use ( within 2 week enrollment ) one following : antidepressant ; regular benzodiazepine ; neuroleptic ; anticonvulsant ; reserpine ; guanethidine ; clonidine ; methyldopa .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Efficacy</keyword>
	<keyword>Antidepressant</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Self Care</keyword>
</DOC>